aluates Reports

$ 0.0

Automative

Global HIV Diagnostics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Othe-0M226

Global HIV Diagnostics Market Insights Forecast to 2028

BUY CHAPTERS

Global HIV Diagnostics Market Research Report 2025

Code: QYRE-Othe-0M226

Report

September 2025

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

HIV Diagnostics Market Size

The global market for HIV Diagnostics was valued at US$ 3099 million in the year 2024 and is projected to reach a revised size of US$ 5444 million by 2031, growing at a CAGR of 8.5% during the forecast period.

HIV Diagnostics Market

The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for HIV Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Diagnostics.

The HIV Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HIV Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HIV Diagnostics Market Report

Report Metric	Details
Report Name	HIV Diagnostics Market
Accounted market size in year	US$ 3099 million
Forecasted market size in 2031	US$ 5444 million
CAGR	8.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Consumables Assay, Kits and Reagents Other Consumables Instruments Software and Services
Segment by Application	Antibody Tests Viral Load Tests CD4 Tests Tests for Early Infant Diagnosis Tests for Viral Identification
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Apogee Flow Systems, PointCare Technologies Inc., Zyomyx Inc., Mylan inc., Roche Diagnostics, Siemens Healthcare, Qiagen, BioMerieux
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is HIV Diagnostics Market growing?

Ans: The HIV Diagnostics Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the HIV Diagnostics Market size in 2031?

Ans: The HIV Diagnostics Market size in 2031 will be US$ 5444 million.

Who are the main players in the HIV Diagnostics Market report?

Ans: The main players in the HIV Diagnostics Market are Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Apogee Flow Systems, PointCare Technologies Inc., Zyomyx Inc., Mylan inc., Roche Diagnostics, Siemens Healthcare, Qiagen, BioMerieux

What are the Application segmentation covered in the HIV Diagnostics Market report?

Ans: The Applications covered in the HIV Diagnostics Market report are Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification

What are the Type segmentation covered in the HIV Diagnostics Market report?

Ans: The Types covered in the HIV Diagnostics Market report are Consumables, Assay, Kits and Reagents, Other Consumables, Instruments, Software and Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HIV Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Consumables

1.2.3 Assay, Kits and Reagents

1.2.4 Other Consumables

1.2.5 Instruments

1.2.6 Software and Services

1.3 Market by Application

1.3.1 Global HIV Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Antibody Tests

1.3.3 Viral Load Tests

1.3.4 CD4 Tests

1.3.5 Tests for Early Infant Diagnosis

1.3.6 Tests for Viral Identification

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global HIV Diagnostics Market Perspective (2020-2031)

2.2 Global HIV Diagnostics Growth Trends by Region

2.2.1 Global HIV Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 HIV Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 HIV Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 HIV Diagnostics Market Dynamics

2.3.1 HIV Diagnostics Industry Trends

2.3.2 HIV Diagnostics Market Drivers

2.3.3 HIV Diagnostics Market Challenges

2.3.4 HIV Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HIV Diagnostics Players by Revenue

3.1.1 Global Top HIV Diagnostics Players by Revenue (2020-2025)

3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by HIV Diagnostics Revenue

3.4 Global HIV Diagnostics Market Concentration Ratio

3.4.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2024

3.5 Global Key Players of HIV Diagnostics Head office and Area Served

3.6 Global Key Players of HIV Diagnostics, Product and Application

3.7 Global Key Players of HIV Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 HIV Diagnostics Breakdown Data by Type

4.1 Global HIV Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global HIV Diagnostics Forecasted Market Size by Type (2026-2031)

5 HIV Diagnostics Breakdown Data by Application

5.1 Global HIV Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global HIV Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America HIV Diagnostics Market Size (2020-2031)

6.2 North America HIV Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America HIV Diagnostics Market Size by Country (2020-2025)

6.4 North America HIV Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe HIV Diagnostics Market Size (2020-2031)

7.2 Europe HIV Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe HIV Diagnostics Market Size by Country (2020-2025)

7.4 Europe HIV Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HIV Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific HIV Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific HIV Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific HIV Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America HIV Diagnostics Market Size (2020-2031)

9.2 Latin America HIV Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America HIV Diagnostics Market Size by Country (2020-2025)

9.4 Latin America HIV Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HIV Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa HIV Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa HIV Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa HIV Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott HIV Diagnostics Introduction

11.1.4 Abbott Revenue in HIV Diagnostics Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 Abbott Healthcare

11.2.1 Abbott Healthcare Company Details

11.2.2 Abbott Healthcare Business Overview

11.2.3 Abbott Healthcare HIV Diagnostics Introduction

11.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2020-2025)

11.2.5 Abbott Healthcare Recent Development

11.3 Abbvie Inc.

11.3.1 Abbvie Inc. Company Details

11.3.2 Abbvie Inc. Business Overview

11.3.3 Abbvie Inc. HIV Diagnostics Introduction

11.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2020-2025)

11.3.5 Abbvie Inc. Recent Development

11.4 Brsitol-Myers Squibb

11.4.1 Brsitol-Myers Squibb Company Details

11.4.2 Brsitol-Myers Squibb Business Overview

11.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction

11.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2020-2025)

11.4.5 Brsitol-Myers Squibb Recent Development

11.5 Janssen Therapeutics

11.5.1 Janssen Therapeutics Company Details

11.5.2 Janssen Therapeutics Business Overview

11.5.3 Janssen Therapeutics HIV Diagnostics Introduction

11.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2020-2025)

11.5.5 Janssen Therapeutics Recent Development

11.6 Gilead Sciences

11.6.1 Gilead Sciences Company Details

11.6.2 Gilead Sciences Business Overview

11.6.3 Gilead Sciences HIV Diagnostics Introduction

11.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2020-2025)

11.6.5 Gilead Sciences Recent Development

11.7 Merck & Co. Inc

11.7.1 Merck & Co. Inc Company Details

11.7.2 Merck & Co. Inc Business Overview

11.7.3 Merck & Co. Inc HIV Diagnostics Introduction

11.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2020-2025)

11.7.5 Merck & Co. Inc Recent Development

11.8 VIIV Healthcare

11.8.1 VIIV Healthcare Company Details

11.8.2 VIIV Healthcare Business Overview

11.8.3 VIIV Healthcare HIV Diagnostics Introduction

11.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2020-2025)

11.8.5 VIIV Healthcare Recent Development

11.9 BD Biosciences

11.9.1 BD Biosciences Company Details

11.9.2 BD Biosciences Business Overview

11.9.3 BD Biosciences HIV Diagnostics Introduction

11.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2020-2025)

11.9.5 BD Biosciences Recent Development

11.10 Beckman Coulter

11.10.1 Beckman Coulter Company Details

11.10.2 Beckman Coulter Business Overview

11.10.3 Beckman Coulter HIV Diagnostics Introduction

11.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2020-2025)

11.10.5 Beckman Coulter Recent Development

11.11 Partec

11.11.1 Partec Company Details

11.11.2 Partec Business Overview

11.11.3 Partec HIV Diagnostics Introduction

11.11.4 Partec Revenue in HIV Diagnostics Business (2020-2025)

11.11.5 Partec Recent Development

11.12 Sysmex

11.12.1 Sysmex Company Details

11.12.2 Sysmex Business Overview

11.12.3 Sysmex HIV Diagnostics Introduction

11.12.4 Sysmex Revenue in HIV Diagnostics Business (2020-2025)

11.12.5 Sysmex Recent Development

11.13 Apogee Flow Systems

11.13.1 Apogee Flow Systems Company Details

11.13.2 Apogee Flow Systems Business Overview

11.13.3 Apogee Flow Systems HIV Diagnostics Introduction

11.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2020-2025)

11.13.5 Apogee Flow Systems Recent Development

11.14 PointCare Technologies Inc.

11.14.1 PointCare Technologies Inc. Company Details

11.14.2 PointCare Technologies Inc. Business Overview

11.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction

11.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2020-2025)

11.14.5 PointCare Technologies Inc. Recent Development

11.15 Zyomyx Inc.

11.15.1 Zyomyx Inc. Company Details

11.15.2 Zyomyx Inc. Business Overview

11.15.3 Zyomyx Inc. HIV Diagnostics Introduction

11.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2020-2025)

11.15.5 Zyomyx Inc. Recent Development

11.16 Mylan inc.

11.16.1 Mylan inc. Company Details

11.16.2 Mylan inc. Business Overview

11.16.3 Mylan inc. HIV Diagnostics Introduction

11.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2020-2025)

11.16.5 Mylan inc. Recent Development

11.17 Roche Diagnostics

11.17.1 Roche Diagnostics Company Details

11.17.2 Roche Diagnostics Business Overview

11.17.3 Roche Diagnostics HIV Diagnostics Introduction

11.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2020-2025)

11.17.5 Roche Diagnostics Recent Development

11.18 Siemens Healthcare

11.18.1 Siemens Healthcare Company Details

11.18.2 Siemens Healthcare Business Overview

11.18.3 Siemens Healthcare HIV Diagnostics Introduction

11.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2020-2025)

11.18.5 Siemens Healthcare Recent Development

11.19 Qiagen

11.19.1 Qiagen Company Details

11.19.2 Qiagen Business Overview

11.19.3 Qiagen HIV Diagnostics Introduction

11.19.4 Qiagen Revenue in HIV Diagnostics Business (2020-2025)

11.19.5 Qiagen Recent Development

11.20 BioMerieux

11.20.1 BioMerieux Company Details

11.20.2 BioMerieux Business Overview

11.20.3 BioMerieux HIV Diagnostics Introduction

11.20.4 BioMerieux Revenue in HIV Diagnostics Business (2020-2025)

11.20.5 BioMerieux Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global HIV Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Consumables

Table 3. Key Players of Assay, Kits and Reagents

Table 4. Key Players of Other Consumables

Table 5. Key Players of Instruments

Table 6. Key Players of Software and Services

Table 7. Global HIV Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global HIV Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global HIV Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global HIV Diagnostics Market Share by Region (2020-2025)

Table 11. Global HIV Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global HIV Diagnostics Market Share by Region (2026-2031)

Table 13. HIV Diagnostics Market Trends

Table 14. HIV Diagnostics Market Drivers

Table 15. HIV Diagnostics Market Challenges

Table 16. HIV Diagnostics Market Restraints

Table 17. Global HIV Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global HIV Diagnostics Market Share by Players (2020-2025)

Table 19. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2024)

Table 20. Ranking of Global Top HIV Diagnostics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by HIV Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of HIV Diagnostics, Headquarters and Area Served

Table 23. Global Key Players of HIV Diagnostics, Product and Application

Table 24. Global Key Players of HIV Diagnostics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global HIV Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global HIV Diagnostics Revenue Market Share by Type (2020-2025)

Table 28. Global HIV Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global HIV Diagnostics Revenue Market Share by Type (2026-2031)

Table 30. Global HIV Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global HIV Diagnostics Revenue Market Share by Application (2020-2025)

Table 32. Global HIV Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global HIV Diagnostics Revenue Market Share by Application (2026-2031)

Table 34. North America HIV Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America HIV Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America HIV Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe HIV Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe HIV Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe HIV Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific HIV Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific HIV Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific HIV Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America HIV Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America HIV Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America HIV Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa HIV Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa HIV Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa HIV Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abbott Company Details

Table 50. Abbott Business Overview

Table 51. Abbott HIV Diagnostics Product

Table 52. Abbott Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 53. Abbott Recent Development

Table 54. Abbott Healthcare Company Details

Table 55. Abbott Healthcare Business Overview

Table 56. Abbott Healthcare HIV Diagnostics Product

Table 57. Abbott Healthcare Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 58. Abbott Healthcare Recent Development

Table 59. Abbvie Inc. Company Details

Table 60. Abbvie Inc. Business Overview

Table 61. Abbvie Inc. HIV Diagnostics Product

Table 62. Abbvie Inc. Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 63. Abbvie Inc. Recent Development

Table 64. Brsitol-Myers Squibb Company Details

Table 65. Brsitol-Myers Squibb Business Overview

Table 66. Brsitol-Myers Squibb HIV Diagnostics Product

Table 67. Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 68. Brsitol-Myers Squibb Recent Development

Table 69. Janssen Therapeutics Company Details

Table 70. Janssen Therapeutics Business Overview

Table 71. Janssen Therapeutics HIV Diagnostics Product

Table 72. Janssen Therapeutics Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 73. Janssen Therapeutics Recent Development

Table 74. Gilead Sciences Company Details

Table 75. Gilead Sciences Business Overview

Table 76. Gilead Sciences HIV Diagnostics Product

Table 77. Gilead Sciences Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 78. Gilead Sciences Recent Development

Table 79. Merck & Co. Inc Company Details

Table 80. Merck & Co. Inc Business Overview

Table 81. Merck & Co. Inc HIV Diagnostics Product

Table 82. Merck & Co. Inc Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 83. Merck & Co. Inc Recent Development

Table 84. VIIV Healthcare Company Details

Table 85. VIIV Healthcare Business Overview

Table 86. VIIV Healthcare HIV Diagnostics Product

Table 87. VIIV Healthcare Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 88. VIIV Healthcare Recent Development

Table 89. BD Biosciences Company Details

Table 90. BD Biosciences Business Overview

Table 91. BD Biosciences HIV Diagnostics Product

Table 92. BD Biosciences Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 93. BD Biosciences Recent Development

Table 94. Beckman Coulter Company Details

Table 95. Beckman Coulter Business Overview

Table 96. Beckman Coulter HIV Diagnostics Product

Table 97. Beckman Coulter Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 98. Beckman Coulter Recent Development

Table 99. Partec Company Details

Table 100. Partec Business Overview

Table 101. Partec HIV Diagnostics Product

Table 102. Partec Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 103. Partec Recent Development

Table 104. Sysmex Company Details

Table 105. Sysmex Business Overview

Table 106. Sysmex HIV Diagnostics Product

Table 107. Sysmex Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 108. Sysmex Recent Development

Table 109. Apogee Flow Systems Company Details

Table 110. Apogee Flow Systems Business Overview

Table 111. Apogee Flow Systems HIV Diagnostics Product

Table 112. Apogee Flow Systems Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 113. Apogee Flow Systems Recent Development

Table 114. PointCare Technologies Inc. Company Details

Table 115. PointCare Technologies Inc. Business Overview

Table 116. PointCare Technologies Inc. HIV Diagnostics Product

Table 117. PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 118. PointCare Technologies Inc. Recent Development

Table 119. Zyomyx Inc. Company Details

Table 120. Zyomyx Inc. Business Overview

Table 121. Zyomyx Inc. HIV Diagnostics Product

Table 122. Zyomyx Inc. Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 123. Zyomyx Inc. Recent Development

Table 124. Mylan inc. Company Details

Table 125. Mylan inc. Business Overview

Table 126. Mylan inc. HIV Diagnostics Product

Table 127. Mylan inc. Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 128. Mylan inc. Recent Development

Table 129. Roche Diagnostics Company Details

Table 130. Roche Diagnostics Business Overview

Table 131. Roche Diagnostics HIV Diagnostics Product

Table 132. Roche Diagnostics Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 133. Roche Diagnostics Recent Development

Table 134. Siemens Healthcare Company Details

Table 135. Siemens Healthcare Business Overview

Table 136. Siemens Healthcare HIV Diagnostics Product

Table 137. Siemens Healthcare Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 138. Siemens Healthcare Recent Development

Table 139. Qiagen Company Details

Table 140. Qiagen Business Overview

Table 141. Qiagen HIV Diagnostics Product

Table 142. Qiagen Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 143. Qiagen Recent Development

Table 144. BioMerieux Company Details

Table 145. BioMerieux Business Overview

Table 146. BioMerieux HIV Diagnostics Product

Table 147. BioMerieux Revenue in HIV Diagnostics Business (2020-2025) & (US$ Million)

Table 148. BioMerieux Recent Development

Table 149. Research Programs/Design for This Report

Table 150. Key Data Information from Secondary Sources

Table 151. Key Data Information from Primary Sources

Table 152. Authors List of This Report

List of Figures

Figure 1. HIV Diagnostics Picture

Figure 2. Global HIV Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global HIV Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Consumables Features

Figure 5. Assay, Kits and Reagents Features

Figure 6. Other Consumables Features

Figure 7. Instruments Features

Figure 8. Software and Services Features

Figure 9. Global HIV Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global HIV Diagnostics Market Share by Application: 2024 VS 2031

Figure 11. Antibody Tests Case Studies

Figure 12. Viral Load Tests Case Studies

Figure 13. CD4 Tests Case Studies

Figure 14. Tests for Early Infant Diagnosis Case Studies

Figure 15. Tests for Viral Identification Case Studies

Figure 16. HIV Diagnostics Report Years Considered

Figure 17. Global HIV Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global HIV Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global HIV Diagnostics Market Share by Region: 2024 VS 2031

Figure 20. Global HIV Diagnostics Market Share by Players in 2024

Figure 21. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by HIV Diagnostics Revenue in 2024

Figure 23. North America HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America HIV Diagnostics Market Share by Country (2020-2031)

Figure 25. United States HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe HIV Diagnostics Market Share by Country (2020-2031)

Figure 29. Germany HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific HIV Diagnostics Market Share by Region (2020-2031)

Figure 37. China HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America HIV Diagnostics Market Share by Country (2020-2031)

Figure 45. Mexico HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa HIV Diagnostics Market Share by Country (2020-2031)

Figure 49. Turkey HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE HIV Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Abbott Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 53. Abbott Healthcare Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 54. Abbvie Inc. Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 55. Brsitol-Myers Squibb Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 56. Janssen Therapeutics Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 57. Gilead Sciences Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 58. Merck & Co. Inc Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 59. VIIV Healthcare Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 60. BD Biosciences Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 61. Beckman Coulter Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 62. Partec Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 63. Sysmex Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 64. Apogee Flow Systems Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 65. PointCare Technologies Inc. Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 66. Zyomyx Inc. Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 67. Mylan inc. Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 68. Roche Diagnostics Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 69. Siemens Healthcare Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 70. Qiagen Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 71. BioMerieux Revenue Growth Rate in HIV Diagnostics Business (2020-2025)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global HIV Diagnostics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Othe-0M226

Global HIV Diagnostics Market Research Report 2025

FEATURED COMPANIES

HIV Diagnostics Market Size

HIV Diagnostics Market

Scope of HIV Diagnostics Market Report

Chapter Outline

FAQ for this report

How fast is HIV Diagnostics Market growing?

What is the HIV Diagnostics Market size in 2031?

Who are the main players in the HIV Diagnostics Market report?

What are the Application segmentation covered in the HIV Diagnostics Market report?

What are the Type segmentation covered in the HIV Diagnostics Market report?

FEATURED COMPANIES